4-oxo-4-(pyridin-3-yl)butanal

Metabolite details

Identifier

CFONOJVUTZAMCB-UHFFFAOYSA-N

InChI Key

CFONOJVUTZAMCB-UHFFFAOYSA-N

IUPAC name

4-oxo-4-(pyridin-3-yl)butanal

Preferred name

4-oxo-4-(pyridin-3-yl)butanal

INN name

—

Synonym

4-oxo-4-(3-pyridinebutanal)

ChEBI

CHEBI:66879

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolomics analysis identifies metabolites associated with systemic acquired resistance in Arabidopsis
• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Changes and correlations of intestinal flora and liver metabolite profiles in mice with gallstones
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Metabolic profilings of rat INS-1 β-cells under changing levels of essential amino acids
• Metabolic disorder and intestinal microflora dysbiosis in chronic inflammatory demyelinating polyradiculoneuropathy
• PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium
• Unraveling the metabolic effects of benzophenone-3 on the endosymbiotic dinoflagellate Cladocopium goreaui

Observed in differential profiles

• Local_Leaf_Control_vs_Local_Leaf_Avr
• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Control_vs_nsPEF_7_day
• Control_vs_Lithogenic_Diet
• G1_PBS_vs_G2_DSS
• G1_Control_vs_G2_Arginine_Addition
• CIDP_patient_vs_healthy_control
• wild_type_vs_patA_deletion
• Control_vs_BP3_Low_Concentration